000 01430 a2200421 4500
005 20250515005317.0
264 0 _c20060413
008 200604s 0 0 eng d
022 _a0267-8357
024 7 _a10.1093/mutage/gei062
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aVan Gompel, J
245 0 0 _aAn assessment of the utility of the yeast GreenScreen assay in pharmaceutical screening.
_h[electronic resource]
260 _bMutagenesis
_cNov 2005
300 _a449-54 p.
_bdigital
500 _aPublication Type: Evaluation Study; Journal Article
650 0 4 _aBiological Assay
_xmethods
650 0 4 _aCarcinogenicity Tests
_xmethods
650 0 4 _aCarcinogens
_xpharmacology
650 0 4 _aCell Count
650 0 4 _aDNA Damage
_xdrug effects
650 0 4 _aDrug Evaluation, Preclinical
_xmethods
650 0 4 _aGenes, Reporter
_xgenetics
650 0 4 _aGreen Fluorescent Proteins
_xgenetics
650 0 4 _aMutagenicity Tests
_xmethods
650 0 4 _aReproducibility of Results
650 0 4 _aSaccharomyces cerevisiae
_xdrug effects
700 1 _aWoestenborghs, F
700 1 _aBeerens, D
700 1 _aMackie, C
700 1 _aCahill, P A
700 1 _aKnight, A W
700 1 _aBillinton, N
700 1 _aTweats, D J
700 1 _aWalmsley, R M
773 0 _tMutagenesis
_gvol. 20
_gno. 6
_gp. 449-54
856 4 0 _uhttps://doi.org/10.1093/mutage/gei062
_zAvailable from publisher's website
999 _c15915852
_d15915852